Hjem › Inflammatorisk tarmsygdom › Texas
Inflammatorisk tarmsygdom kliniske forsøg i Texas
16 studier for Inflammatorisk tarmsygdom søger deltagere på steder i Texas.
Byer i Texas
- Houston8 studier
- Round Rock5 studier
- Tyler5 studier
- Garland4 studier
- Fort Worth4 studier
- Lewisville4 studier
- San Antonio3 studier
- League City3 studier
- Lubbock3 studier
Officiel studietekst (engelsk)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research, Baytown
- DHR Health Gastroenterology - Edinburg, Edinburg
- Baylor College of Medicine, Houston
- og 3 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 30. sep. 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cedar Park
- Xencor Investigative Site, Denton
- Xencor Investigative Site, Garland
- og 8 flere
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 013, Cedar Park
- Site 005, Garland
- Site 002, San Antonio
- og 2 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-024, Garland
- Site US-009, Georgetown
- Site US-030, Houston
- og 4 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cook Childrens Medical Center, Fort Worth
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 25. sep. 2026 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- og 2 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345Study of DISC-0974-201 in Participants With IBD and Anemia
- One of a Kind Clinical Research Center, LLC, Kingwood
- Siena Research Network, Sugar Land
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07368972A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- GI Alliance - Cedar Park, Cedar Park
- North Texas Gastroenterology, Denton
- The University of Texas Health Science Center at Houston, Houston
- og 3 flere
RekruttererFase 2
Alder 18 til 85 · Alle køn · Opdateret 22. sep. 2026 · NCT06226883A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
RekruttererFase 3
Alder 2 til 19 · Alle køn · Opdateret 22. sep. 2026 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cook Children's Medical Center, Fort Worth
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 24. aug. 2026 · NCT05509777BOOM-IBD2 Pivotal Clinical Trial
- Amarillo Premier Research (Objective Health), Amarillo
- Digestive Research of Central Texas (Objective Health), Waco
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 6. aug. 2026 · NCT06571669HB-adMSCs for the Treatment of Crohn's Disease
- Hope Biosciences Research Foundation, Sugar Land
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 6. aug. 2026 · NCT07077746Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 20. maj 2026 · NCT04751396A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- og 5 flere
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 11. mar. 2026 · NCT07210580Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
RekruttererObservationsstudie
Alder 18 til 100 · Alle køn · Opdateret 18. maj 2021 · NCT04617184Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.